Search

On September 4, China's Ministry of Industry and Information Technology and State Administration for Market Regulation released an action plan targeting 7% annual growth in industrial added value for the electronic information manufacturing sector (2025-2026). The plan prioritizes 6G, photovoltaics, and lithium batteries, with the goal of establishing five trillion-yuan provincial industrial clusters by 2026.

New rules for importing urgently needed Hong Kong and Macao medical products into the Greater Bay Area were announced on September 15, effective November 1, 2025.

On September 15, Dongguan unveiled 14 measures to boost its low-altitude economy through infrastructure and industrial chain development.

On September 16, Guangdong province issued an action plan (2025-2027) to boost its toy industry with AI. The plan will use provincial funds to support key AI projects and equipment upgrades. Eligible companies, including specialized SMEs, will receive subsidies and loan interest support.

On September 15, Guangdong introduced new rules enabling Greater Bay Area hospitals to use urgently needed Hong Kong and Macao medical products. The policy now covers 45 hospitals with 125 approved products, benefiting over 10,000 patients.

HKTDC Report September 15 Hong Kongs biopharmaceutical sector grew nearly 30 percent in the past decade with over 3000 enterprises and with new Guangdong policies the Greater Bay Area is expected to see major business opportunities in this industry

At the 15 September Guangzhou session on accelerating Guangdong’s modern industrial system, dedicated to high-calibre talent, Social Development Committee Chair Huang Li reported intensified recruitment and a refined Guangdong–Hong Kong–Macao joint mechanism, enabling 8 019 Hong Kong and Macao professionals to practise seamlessly on the mainland

With 92 generative AI models already filed—second nationally—Guangdong orchestrates province-city-zone policies across manufacturing, mobility, education and beyond, uniting incumbents and start-ups behind leading patents and compute, anchoring high-grade “AI Plus” expansion for the Greater Bay Area

The GBA is forging a trillion-yuan biopharma belt, pairing Hong Kong's finance, trial and regulatory gateways with Guangdong’s parks, labs and plants to accelerate drug-and-device commercialization at home and abroad

The Ministry of Industry and Information Technology’s 2025 5G Factory Directory lists 560 projects spanning 48 sectors, with 46 sited in the Greater Bay Area

On 8 September Guangzhou launched the GBA AI Standardisation Task Force to unify academia, industry and users in drafting scenario-validated standards and to build a Bay-area pilot-to-production platform offering full-cycle technical services

Guangdong data released 9 September show 260 000+ Hong Kong and Macao firms now registered; 2024 two-way trade topped RMB 1 trillion. The trio jointly commands 70 % of global consumer drones, 40 % of smartphones, one-quarter of China's NEVs and one-fifth of its ICs, signaling a decisive advance in regional integration

Guangdong is offering rewards and subsidies to support the development of the AI and robotics industries in the province. The initiative will focus on establishing manufacturing innovation centres in AI and robotics, helping to nurture high-calibre enterprises and launching demonstration projects for AI-driven industrial upgrading. Incentives of up to RMB50 million may be offered for a single programme.

The State Council is putting together plans to deepen the implementation of Mainland China’s Artificial Intelligence Plus (AI Plus) initiative. This will drive the integration of AI across six key areas, including science and technology, industrial development, consumption upgrades, public services and governance.

Seven state agencies, including the People’s Bank of China, have jointly issued a guideline for developing a financial system to support the advancement of new industrialisation. The guideline calls for providing financing in the form of loans, bonds and equity. This will be achieved through 18 measures, including the optimisation of financial policy tools, the attraction of long-term funds and the development of patient capital.